» Articles » PMID: 35774233

POLQ Suppresses Genome Instability and Alterations In DNA Repeat Tract Lengths

Overview
Journal NAR Cancer
Specialty Oncology
Date 2022 Jul 1
PMID 35774233
Authors
Affiliations
Soon will be listed here.
Abstract

DNA polymerase theta (POLQ) is a principal component of the alternative non-homologous end-joining (ANHEJ) DNA repair pathway that ligates DNA double-strand breaks. Utilizing independent models of POLQ insufficiency during telomere-driven crisis, we found that  cells are resistant to crisis-induced growth deceleration despite sustaining inter-chromosomal telomere fusion frequencies equivalent to wild-type (WT) cells. We recorded longer telomeres in than WT cells pre- and post-crisis, notwithstanding elevated total telomere erosion and fusion rates. cells emerging from crisis exhibited reduced incidence of clonal gross chromosomal abnormalities in accordance with increased genetic heterogeneity. High-throughput sequencing of telomere fusion amplicons from POLQ-deficient cells revealed significantly raised frequencies of inter-chromosomal fusions with correspondingly depreciated intra-chromosomal recombinations. Long-range interactions culminating in telomere fusions with centromere alpha-satellite repeats, as well as expansions in HSAT2 and HSAT3 satellite and contractions in ribosomal DNA repeats, were detected in cells. In conjunction with the expanded telomere lengths of cells, these results indicate a hitherto unrealized capacity of POLQ for regulation of repeat arrays within the genome. Our findings uncover novel considerations for the efficacy of POLQ inhibitors in clinical cancer interventions, where potential genome destabilizing consequences could drive clonal evolution and resistant disease.

Citing Articles

Polθ Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells.

Barszczewska-Pietraszek G, Czarny P, Drzewiecka M, Blaszczyk M, Radek M, Synowiec E Int J Mol Sci. 2024; 25(17).

PMID: 39273083 PMC: 11395082. DOI: 10.3390/ijms25179134.


Multifaceted Nature of DNA Polymerase θ.

Kruchinin A, Makarova A Int J Mol Sci. 2023; 24(4).

PMID: 36835031 PMC: 9962433. DOI: 10.3390/ijms24043619.


Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours.

Barszczewska-Pietraszek G, Drzewiecka M, Czarny P, Skorski T, Sliwinski T Int J Mol Sci. 2023; 24(1).

PMID: 36613762 PMC: 9820168. DOI: 10.3390/ijms24010319.

References
1.
Davis L, Khoo K, Zhang Y, Maizels N . POLQ suppresses interhomolog recombination and loss of heterozygosity at targeted DNA breaks. Proc Natl Acad Sci U S A. 2020; 117(37):22900-22909. PMC: 7502765. DOI: 10.1073/pnas.2008073117. View

2.
Hussain S, Majumdar R, Moore G, Narang H, Buechelmaier E, Bazil M . Measuring nonhomologous end-joining, homologous recombination and alternative end-joining simultaneously at an endogenous locus in any transfectable human cell. Nucleic Acids Res. 2021; 49(13):e74. PMC: 8287935. DOI: 10.1093/nar/gkab262. View

3.
Schawalder J, Paric E, Neff N . Telomere and ribosomal DNA repeats are chromosomal targets of the bloom syndrome DNA helicase. BMC Cell Biol. 2003; 4:15. PMC: 270065. DOI: 10.1186/1471-2121-4-15. View

4.
Liddiard K, Ruis B, Takasugi T, Harvey A, Ashelford K, Hendrickson E . Sister chromatid telomere fusions, but not NHEJ-mediated inter-chromosomal telomere fusions, occur independently of DNA ligases 3 and 4. Genome Res. 2016; 26(5):588-600. PMC: 4864465. DOI: 10.1101/gr.200840.115. View

5.
Rai R, Gu P, Broton C, Kumar-Sinha C, Chen Y, Chang S . The Replisome Mediates A-NHEJ Repair of Telomeres Lacking POT1-TPP1 Independently of MRN Function. Cell Rep. 2019; 29(11):3708-3725.e5. PMC: 7001145. DOI: 10.1016/j.celrep.2019.11.012. View